Literature DB >> 20232462

FT-IR, Raman, RRS measurements and DFT calculation for doxorubicin.

Gobind Das1, Annalisa Nicastri, Maria Laura Coluccio, Francesco Gentile, Patrizio Candeloro, Gheorghe Cojoc, Carlo Liberale, Francesco De Angelis, Enzo Di Fabrizio.   

Abstract

Doxorubicin (DOXO) is a powerful anthracycline antibiotic used to treat many human neoplasms, including acute leukemias, lymphomas, stomach, breast and ovarian cancer, and bone tumors, yet causing cardiotoxicity at the same time. For this reason, there is a great interest in medical field to gain deep insight and knowledge of this molecule. Raman, Fourier Transform Infrared (FT-IR) absorption spectroscopy, and Resonance Raman scattering were performed for the vibrational characterization of DOXO molecule. Density function theorem (DFT) modeling of Raman and FT-IR spectra were used for the assignment of the vibrational frequencies. The optimized molecular structured was obtained, first, on the basis of potential energy distribution. The simulation for vibrational bands is based on the calculations for internal force constants and potential energy distribution matrices. The calculated DOXO vibrational bands show qualitative agreement with the experimental observations (FT-IR absorption and Raman scattering).
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232462     DOI: 10.1002/jemt.20849

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  12 in total

1.  Nanocarriers enhance Doxorubicin uptake in drug-resistant ovarian cancer cells.

Authors:  Hans C Arora; Mark P Jensen; Ye Yuan; Aiguo Wu; Stefan Vogt; Tatjana Paunesku; Gayle E Woloschak
Journal:  Cancer Res       Date:  2011-12-12       Impact factor: 12.701

2.  Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs.

Authors:  Snehal K Shukla; Apoorva Sarode; Dipti D Kanabar; Aaron Muth; Nitesh K Kunda; Samir Mitragotri; Vivek Gupta
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2021-07-15

3.  Doxorubicin-Wrapped Zinc Oxide Nanoclusters for the Therapy of Colorectal Adenocarcinoma.

Authors:  Sungyun Kim; Song Yi Lee; Hyun-Jong Cho
Journal:  Nanomaterials (Basel)       Date:  2017-10-28       Impact factor: 5.076

4.  Synthesis, characterization, and interactions of single-walled carbon nanotubes modified with doxorubicin with Langmuir-Blodgett biomimetic membranes.

Authors:  Dorota Matyszewska; Ewelina Napora; Kamila Żelechowska; Jan F Biernat; Renata Bilewicz
Journal:  J Nanopart Res       Date:  2018-05-12       Impact factor: 2.253

5.  Overcoming multidrug resistance through inhalable siRNA nanoparticles-decorated porous microparticles based on supercritical fluid technology.

Authors:  Pei-Yao Xu; Ranjith Kumar Kankala; Yu-Jing Pan; Hui Yuan; Shi-Bin Wang; Ai-Zheng Chen
Journal:  Int J Nanomedicine       Date:  2018-08-15

6.  Functionalized Large-Pore Mesoporous Silica Microparticles for Gefitinib and Doxorubicin Codelivery.

Authors:  Yan Li; Fangxiang Song; Liang Cheng; Jin Qian; Qianlin Chen
Journal:  Materials (Basel)       Date:  2019-03-06       Impact factor: 3.623

7.  Multimodal Gold Nanostars as SERS Tags for Optically-Driven Doxorubicin Release Study in Cancer Cells.

Authors:  Luca Minati; Devid Maniglio; Filippo Benetti; Andrea Chiappini; Giorgio Speranza
Journal:  Materials (Basel)       Date:  2021-11-28       Impact factor: 3.623

8.  3D coaxial out-of-plane metallic antennas for filtering and multi-spectral imaging in the infrared range.

Authors:  Andrea Jacassi; Angelo Bozzola; Pierfrancesco Zilio; Francesco Tantussi; Francesco De Angelis
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

9.  Newly Synthesized Doxorubicin Complexes with Selected Metals-Synthesis, Structure and Anti-Breast Cancer Activity.

Authors:  Agata Jabłońska-Trypuć; Grzegorz Świderski; Rafał Krętowski; Włodzimierz Lewandowski
Journal:  Molecules       Date:  2017-07-04       Impact factor: 4.411

10.  Poly(3-Hydroxybutyrate)-Based Nanoparticles for Sorafenib and Doxorubicin Anticancer Drug Delivery.

Authors:  György Babos; Joanna Rydz; Michal Kawalec; Magdalena Klim; Andrea Fodor-Kardos; László Trif; Tivadar Feczkó
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.